{"result": {"id": "2b5ec2aa-dfa0-4e3c-a321-e910bf5cfe89", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>BRGULJAN-HITIJ J<|>PERSON<|>A researcher involved in a meta-analysis on home blood pressure risk stratification\")  \n##  \n(\"entity\"<|>KUSHIRO T<|>PERSON<|>A researcher involved in a large-scale observational study on home blood pressure and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>SAITO I<|>PERSON<|>A researcher involved in a large-scale observational study on home blood pressure and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>SONG L<|>PERSON<|>A researcher involved in a study on blood pressure variability and mortality risk\")  \n##  \n(\"entity\"<|>LI X<|>PERSON<|>A researcher involved in a study on blood pressure variability and mortality risk\")  \n##  \n(\"entity\"<|>YANG WY<|>PERSON<|>A researcher involved in a study on isolated diastolic hypertension\")  \n##  \n(\"entity\"<|>APARICIO LS<|>PERSON<|>A researcher involved in studies on pulsatile blood pressure components and risk stratification\")  \n##  \n(\"entity\"<|>SALADINI F<|>PERSON<|>A researcher involved in a study on short-term blood pressure variability\")  \n##  \n(\"entity\"<|>MOS L<|>PERSON<|>A researcher involved in a study on short-term blood pressure variability\")  \n##  \n(\"entity\"<|>GRUNDY SM<|>PERSON<|>A researcher involved in a study on cardiovascular incidence related to diabetes and metabolic syndrome\")  \n##  \n(\"entity\"<|>WANG W<|>PERSON<|>A researcher involved in a study on cardiovascular incidence related to diabetes and metabolic syndrome\")  \n##  \n(\"entity\"<|>XU Y<|>PERSON<|>A researcher involved in a study on hypertension and cardiovascular disease risk\")  \n##  \n(\"entity\"<|>ZHENG R<|>PERSON<|>A researcher involved in a study on hypertension and cardiovascular disease risk\")  \n##  \n(\"entity\"<|>REN H<|>PERSON<|>A researcher involved in a study on nighttime masked uncontrolled hypertension\")  \n##  \n(\"entity\"<|>XIE J<|>PERSON<|>A researcher involved in a study on nighttime masked uncontrolled hypertension\")  \n##  \n(\"entity\"<|>CORESH J<|>PERSON<|>A researcher involved in a meta-analysis on glomerular filtration rate and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>SANG Y<|>PERSON<|>A researcher involved in a meta-analysis on glomerular filtration rate and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>HAN X<|>PERSON<|>A researcher involved in a study on long-term cardiovascular risk associated with stage 1 hypertension\")  \n##  \n(\"entity\"<|>WANG M<|>PERSON<|>A researcher involved in epidemiology studies on cardiovascular disease in China\")  \n##  \n(\"entity\"<|>WANG H<|>PERSON<|>A researcher involved in a systematic analysis of mortality and morbidity in China\")  \n##  \n(\"entity\"<|>ZENG X<|>PERSON<|>A researcher involved in a systematic analysis of mortality and morbidity in China\")  \n##  \n(\"entity\"<|>CHEN X<|>PERSON<|>A researcher involved in a study comparing blood pressure measurement methods\")  \n##  \n(\"entity\"<|>SHENG CS<|>PERSON<|>A researcher involved in a study comparing blood pressure measurement methods\")  \n##  \n(\"entity\"<|>CHIA YC<|>PERSON<|>A researcher involved in the HOPE Asia Network consensus on blood pressure measurements\")  \n##  \n(\"relationship\"<|>ASAYAMA K<|>PLOS MED<|>Asayama K co-authored a meta-analysis published in PLoS Med<|>6\")  \n##  \n(\"relationship\"<|>BRGULJAN-HITIJ J<|>PLOS MED<|>Brguljan-Hitij J co-authored a meta-analysis published in PLoS Med<|>6\")  \n##  \n(\"relationship\"<|>KARIO K<|>HONEST STUDY<|>Kario K led the HONEST study on home blood pressure<|>7\")  \n##  \n(\"relationship\"<|>SAITO I<|>HONEST STUDY<|>Saito I co-authored the HONEST study<|>6\")  \n##  \n(\"relationship\"<|>KUSHIRI T<|>HONEST STUDY<|>Kushiro T co-authored the HONEST study<|>6\")  \n##  \n(\"relationship\"<|>DAI L<|>SONG L<|>Dai L and Song L co-authored a study on blood pressure variability<|>5\")  \n##  \n(\"relationship\"<|>DAI L<|>LI X<|>Dai L and Li X co-authored a study on blood pressure variability<|>5\")  \n##  \n(\"relationship\"<|>MCEVOY JW<|>YANG WY<|>McEvoy JW and Yang WY co-authored a study on isolated diastolic hypertension<|>5\")  \n##  \n(\"relationship\"<|>HUANG QF<|>APARICIO LS<|>Huang QF and Aparicio LS co-authored a study on pulsatile blood pressure<|>5\")  \n##  \n(\"relationship\"<|>CHENG YB<|>APARICIO LS<|>Cheng YB and Aparicio LS co-authored the IDCARS study<|>5\")  \n##  \n(\"relationship\"<|>PALATINI P<|>SALADINI F<|>Palatini P and Saladini F co-authored a study on blood pressure variability<|>5\")  \n##  \n(\"relationship\"<|>PALATINI P<|>MOS L<|>Palatini P and Mos L co-authored a study on blood pressure variability<|>5\")  \n##  \n(\"relationship\"<|>LIU J<|>GRUNDY SM<|>Liu J and Grundy SM co-authored a study on cardiovascular risk<|>5\")  \n##  \n(\"relationship\"<|>LIU J<|>WANG W<|>Liu J and Wang W co-authored a study on cardiovascular risk<|>5\")  \n##  \n(\"relationship\"<|>WU S<|>XU Y<|>Wu S and Xu Y co-authored a study on hypertension guidelines<|>5\")  \n##  \n(\"relationship\"<|>WU S<|>ZHENG R<|>Wu S and Zheng R co-authored a study on hypertension guidelines<|>5\")  \n##  \n(\"relationship\"<|>FU X<|>REN H<|>Fu X and Ren H co-authored a study on nighttime hypertension<|>5\")  \n##  \n(\"relationship\"<|>FU X<|>XIE J<|>Fu X and Xie J co-authored a study on nighttime hypertension<|>5\")  \n##  \n(\"relationship\"<|>MATSUSHITA K<|>CORESH J<|>Matsushita K and Coresh J co-authored a meta-analysis on kidney function<|>5\")  \n##  \n(\"relationship\"<|>MATSUSHITA K<|>SANG Y<|>Matsushita K and Sang Y co-authored a meta-analysis on kidney function<|>5\")  \n##  \n(\"relationship\"<|>QI Y<|>HAN X<|>Qi Y and Han X co-authored a study on stage 1 hypertension<|>5\")  \n##  \n(\"relationship\"<|>ZHAO D<|>WANG M<|>Zhao D and Wang M co-authored an epidemiology study on cardiovascular disease<|>5\")  \n##  \n(\"relationship\"<|>ZHOU M<|>WANG H<|>Zhou M and Wang H co-authored a systematic analysis of mortality in China<|>5\")  \n##  \n(\"relationship\"<|>ZHOU M<|>ZENG X<|>Zhou M and Zeng X co-authored a systematic analysis of mortality in China<|>5\")  \n##  \n(\"relationship\"<|>XU SK<|>CHEN X<|>Xu SK and Chen X co-authored a study on blood pressure measurement methods<|>5\")  \n##  \n(\"relationship\"<|>XU SK<|>SHENG CS<|>Xu SK and Sheng CS co-authored a study on blood pressure measurement methods<|>5\")  \n##  \n(\"relationship\"<|>SHIN J<|>CHIA YC<|>Shin J and Chia YC contributed to the HOPE Asia Network consensus<|>5\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558953, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1948, "prompt_tokens": 5225, "total_tokens": 7173, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3648}, "prompt_cache_hit_tokens": 3648, "prompt_cache_miss_tokens": 1577}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , Melgarejo JD, ThijsL, etal.  Association ofoffice and ambulatorybloodpressurewithmortalityandcardiovascular outcomes[J]. JAMA,2019,322(5) :409-420.\n[59]  AsayamaK, ThijsL, Brguljan-HitijJ, etal. Risk stratification by self-measured home blood pressure across categories of con- ventionalblood pressure: a participant-level meta-analysis[J].   PLoSMed,2014,11(1) :e1001591.\n[60]  KarioK, Saito I, KushiroT, etal.  Home blood pressure and cardiovascularoutcomesinpatientsduringantihypertensivether- apy: primaryresultsofHONEST, alarge-scaleprospective, re- al-worldobservationalstudy[J]. Hypertension,2014,64(5) :989- 996.\n[61]  DaiL, Song L, LiX, et al.  Association of visit-to-visitblood pressurevariabilitywiththeriskofall-causemortalityandcardi- ovascular events in general population[J]. J Clin Hypertens (Greenwich) ,2018,20(2) :280-288.\n[62]  McEvoyJW , YangWY, ThijsL, etal. Isolateddiastolichyper- tension in theIDACO study: an age-stratifiedanalysisusing24- hourambulatory blood pressure measurements[J]. Hyperten- sion,2021,78(5) :1222-1231.\n[63]  HuangQF, AparicioLS, ThijsL, etal.  Cardiovascularendpoints and mortality arenotcloserassociatedwith centralthan periph- eral pulsatile blood pressure components[J].  Hypertension,  2020,76(2) :350-358.\n[64]  ChengYB, ThijsL, AparicioLS, etal.  Internationaldatabase ofcentralarterialpropertiesforrisk stratification(IDCARS) in- vestigators.  Risk stratification by cross-classification of central and brachialsystolic blood pressure[J]. Hypertension, 2022, 79\n(5) :1101-1111.\n[65]  PalatiniP, SaladiniF, MosL, etal. Short-term blood pressure variabilityoutweighsaverage24-h blood pressure in the predic- tion ofcardiovascular events in hypertension ofthe young[J]. J Hypertens,2019,37(7) :1419-1426.\n[66]  LiuJ, GrundySM, WangW , etal. Ten-yearrisk ofcardiovas- cularincidence related to diabetes, prediabetes, and the meta- bolicsyndrome[J]. Am HeartJ,2007,153(4) :552-558.\n[67]  Wu S, Xu Y, Zheng R, et al.  Hypertension defined by 2017\n\n\n\nACC/AHA guideline, ideal cardiovascular health metrics, and risk of cardiovascular disease: a nationwide prospective cohort study[J]. LancetReg HealthWestPac,2022,20:100350.\n[68]  FuX, Ren H, XieJ, etal. Associationofnighttimemaskedun- controlled hypertension with left ventricular hypertrophy and kidneyfunction among patients with chronic kidney disease not receivingdialysis[J]. JAMANetw Open,2022,5(5) :e2214460.\n[69]  MatsushitaK, CoreshJ, Sang Y, et al.  Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborativemeta-analysis ofindividualparticipant data[J]. LancetDiabetesEndocrinol,2015,3(7) :514-525.\n[70]  国家心血管病中心.  中国心血管健康与疾病报告 2022[M]. 北 京 : 中国协和医科大学出版社 ,2022:114.\n[71]  QiY, Han X, ZhaoD, etal. Long-term cardiovascularrisk as- sociated with stage 1 hypertension defined by the 2017 ACC/ AHA hypertension guideline[J]. J Am Coll Cardiol, 2018, 72\n(11) :1201-1210.\n[72]  Zhao D, LiuJ, WangM, etal. Epidemiology ofcardiovascular diseasein China: currentfeatures and implications[J]. NatRev Cardiol,2019,16(4) :203-212.\n[73]  Zhou M, Wang H, Zeng X, et al.  Mortality, morbidity, and riskfactorsinChinaanditsprovinces, 1990   2017: asystematic analysisfortheGlobalBurdenofDiseaseStudy2017[J]. Lancet,  2019,394(10204) :1145-1158.\n[74]  XuSK, Chen X, ShengCS, etal.  Comparison ofthe mean of thefirst two blood pressure readings with the overall mean of three readings on a single occasion[J]. J Hypertens, 2022, 40\n(4) :699-703.\n[75]  ShinJ, Wang JG, Chia YC, et al.  The HOPE Asia Network consensuson blood pressuremeasurements corresponding to of- fice measurements:  automated office,\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>JAMA<|>ORGANIZATION<|>JAMA is a medical journal that published a study on the association of office and ambulatory blood pressure with mortality and cardiovascular outcomes in 2019\")  \n##  \n(\"entity\"<|>PLOS MED<|>ORGANIZATION<|>PLoS Med is a medical journal that published a meta-analysis on risk stratification by self-measured home blood pressure in 2014\")  \n##  \n(\"entity\"<|>HYPERTENSION<|>ORGANIZATION<|>Hypertension is a medical journal that published studies on home blood pressure and cardiovascular outcomes, as well as other hypertension-related research\")  \n##  \n(\"entity\"<|>J CLIN HYPERTENS (GREENWICH)<|>ORGANIZATION<|>A medical journal that published research on blood pressure variability and its association with mortality and cardiovascular events\")  \n##  \n(\"entity\"<|>IDACO STUDY<|>ORGANIZATION<|>A study analyzing isolated diastolic hypertension using 24-hour ambulatory blood pressure measurements\")  \n##  \n(\"entity\"<|>IDCARS<|>ORGANIZATION<|>International Database of Central Arterial Properties for Risk Stratification, which investigates risk stratification by blood pressure components\")  \n##  \n(\"entity\"<|>AM HEART J<|>ORGANIZATION<|>A medical journal that published research on cardiovascular incidence related to diabetes and metabolic syndrome\")  \n##  \n(\"entity\"<|>LANCET REG HEALTH WEST PAC<|>ORGANIZATION<|>A regional health journal that published a study on hypertension and cardiovascular disease risk\")  \n##  \n(\"entity\"<|>JAMA NETW OPEN<|>ORGANIZATION<|>A medical journal that published research on nighttime masked uncontrolled hypertension and its effects\")  \n##  \n(\"entity\"<|>LANCET DIABETES ENDOCRINOL<|>ORGANIZATION<|>A medical journal that published a meta-analysis on estimated glomerular filtration rate and albuminuria for cardiovascular outcomes prediction\")  \n##  \n(\"entity\"<|>NATIONAL CENTER FOR CARDIOVASCULAR DISEASES, CHINA<|>ORGANIZATION<|>A research center that published the 2022 report on cardiovascular health and diseases in China\")  \n##  \n(\"entity\"<|>J AM COLL CARDIOL<|>ORGANIZATION<|>A medical journal that published research on long-term cardiovascular risk associated with stage 1 hypertension\")  \n##  \n(\"entity\"<|>NAT REV CARDIOL<|>ORGANIZATION<|>A medical journal that published an epidemiology study on cardiovascular disease in China\")  \n##  \n(\"entity\"<|>LANCET<|>ORGANIZATION<|>A medical journal that published a systematic analysis of mortality, morbidity, and risk factors in China\")  \n##  \n(\"entity\"<|>HOPE ASIA NETWORK<|>ORGANIZATION<|>A network that published consensus guidelines on blood pressure measurements\")  \n##  \n(\"entity\"<|>MELGAREJO JD<|>PERSON<|>A researcher associated with a study on office and ambulatory blood pressure published in JAMA\")  \n##  \n(\"entity\"<|>THIJS L<|>PERSON<|>A researcher involved in multiple studies on blood pressure and cardiovascular risk\")  \n##  \n(\"entity\"<|>ASAYAMA K<|>PERSON<|>A researcher involved in a meta-analysis on home blood pressure risk stratification\")  \n##  \n(\"entity\"<|>KARIO K<|>PERSON<|>A researcher involved in a large-scale observational study on home blood pressure and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>DAI L<|>PERSON<|>A researcher involved in a study on blood pressure variability and mortality risk\")  \n##  \n(\"entity\"<|>MCEVOY JW<|>PERSON<|>A researcher involved in a study on isolated diastolic hypertension\")  \n##  \n(\"entity\"<|>HUANG QF<|>PERSON<|>A researcher involved in a study on pulsatile blood pressure components\")  \n##  \n(\"entity\"<|>CHENG YB<|>PERSON<|>A researcher involved in the IDCARS study on central and brachial blood pressure\")  \n##  \n(\"entity\"<|>PALATINI P<|>PERSON<|>A researcher involved in a study on short-term blood pressure variability\")  \n##  \n(\"entity\"<|>LIU J<|>PERSON<|>A researcher involved in studies on cardiovascular risk and epidemiology\")  \n##  \n(\"entity\"<|>WU S<|>PERSON<|>A researcher involved in a study on hypertension and cardiovascular disease risk\")  \n##  \n(\"entity\"<|>FU X<|>PERSON<|>A researcher involved in a study on nighttime masked uncontrolled hypertension\")  \n##  \n(\"entity\"<|>MATSUSHITA K<|>PERSON<|>A researcher involved in a meta-analysis on glomerular filtration rate and cardiovascular outcomes\")  \n##  \n(\"entity\"<|>QI Y<|>PERSON<|>A researcher involved in a study on long-term cardiovascular risk associated with stage 1 hypertension\")  \n##  \n(\"entity\"<|>ZHAO D<|>PERSON<|>A researcher involved in epidemiology studies on cardiovascular disease in China\")  \n##  \n(\"entity\"<|>ZHOU M<|>PERSON<|>A researcher involved in a systematic analysis of mortality and morbidity in China\")  \n##  \n(\"entity\"<|>XU SK<|>PERSON<|>A researcher involved in a study comparing blood pressure measurement methods\")  \n##  \n(\"entity\"<|>SHIN J<|>PERSON<|>A researcher involved in the HOPE Asia Network consensus on blood pressure measurements\")  \n##  \n(\"entity\"<|>CHINA<|>GEO<|>A country where multiple cardiovascular studies and epidemiological analyses were conducted\")  \n##  \n(\"entity\"<|>BEIJING<|>GEO<|>The capital of China, where the National Center for Cardiovascular Diseases is located\")  \n##  \n(\"relationship\"<|>THIJS L<|>JAMA<|>Thijs L co-authored a study published in JAMA<|>6\")  \n##  \n(\"relationship\"<|>THIJS L<|>PLOS MED<|>Thijs L co-authored a meta-analysis published in PLoS Med<|>6\")  \n##  \n(\"relationship\"<|>THIJS L<|>HYPERTENSION<|>Thijs L co-authored multiple studies published in Hypertension<|>7\")  \n##  \n(\"relationship\"<|>THIJS L<|>IDACO STUDY<|>Thijs L was involved in the IDACO study<|>5\")  \n##  \n(\"relationship\"<|>THIJS L<|>IDCARS<|>Thijs L was involved in the IDCARS study<|>5\")  \n##  \n(\"relationship\"<|>KARIO K<|>HYPERTENSION<|>Kario K led a large-scale study published in Hypertension<|>7\")  \n##  \n(\"relationship\"<|>DAI L<|>J CLIN HYPERTENS (GREENWICH)<|>Dai L co-authored a study published in J Clin Hypertens<|>6\")  \n##  \n(\"relationship\"<|>MCEVOY JW<|>HYPERTENSION<|>McEvoy JW co-authored a study published in Hypertension<|>6\")  \n##  \n(\"relationship\"<|>HUANG QF<|>HYPERTENSION<|>Huang QF co-authored a study published in Hypertension<|>6\")  \n##  \n(\"relationship\"<|>CHENG YB<|>HYPERTENSION<|>Cheng YB co-authored a study published in Hypertension<|>6\")  \n##  \n(\"relationship\"<|>PALATINI P<|>J HYPERTENS<|>Palatini P co-authored a study published in J Hypertens<|>6\")  \n##  \n(\"relationship\"<|>LIU J<|>AM HEART J<|>Liu J co-authored a study published in Am Heart J<|>6\")  \n##  \n(\"relationship\"<|>WU S<|>LANCET REG HEALTH WEST PAC<|>Wu S co-authored a study published in Lancet Reg Health West Pac<|>6\")  \n##  \n(\"relationship\"<|>FU X<|>JAMA NETW OPEN<|>Fu X co-authored a study published in JAMA Netw Open<|>6\")  \n##  \n(\"relationship\"<|>MATSUSHITA K<|>LANCET DIABETES ENDOCRINOL<|>Matsushita K co-authored a meta-analysis published in Lancet Diabetes Endocrinol<|>6\")  \n##  \n(\"relationship\"<|>QI Y<|>J AM COLL CARDIOL<|>Qi Y co-authored a study published in J Am Coll Cardiol<|>6\")  \n##  \n(\"relationship\"<|>ZHAO D<|>NAT REV CARDIOL<|>Zhao D co-authored an epidemiology study published in Nat Rev Cardiol<|>6\")  \n##  \n(\"relationship\"<|>ZHOU M<|>LANCET<|>Zhou M co-authored a systematic analysis published in Lancet<|>6\")  \n##  \n(\"relationship\"<|>XU SK<|>J HYPERTENS<|>Xu SK co-authored a study published in J Hypertens<|>6\")  \n##  \n(\"relationship\"<|>SHIN J<|>HOPE ASIA NETWORK<|>Shin J contributed to the HOPE Asia Network consensus<|>6\")  \n##  \n(\"relationship\"<|>NATIONAL CENTER FOR CARDIOVASCULAR DISEASES, CHINA<|>BEIJING<|>The National Center for Cardiovascular Diseases is located in Beijing<|>8\")  \n##  \n(\"relationship\"<|>NATIONAL CENTER FOR CARDIOVASCULAR DISEASES, CHINA<|>CHINA<|>The center conducts research on cardiovascular health in China<|>8\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_a926d8ab31f6e9df0724d3ecf589ccf4555393ac54e9be47c41a4991bfff8365_v2"}